Comment on "Diagnostic testing of eczematous dermatitis with incomplete response to dupilumab"
- PMID: 35933070
- DOI: 10.1016/j.jaad.2022.05.069
Comment on "Diagnostic testing of eczematous dermatitis with incomplete response to dupilumab"
Keywords: Sézary syndrome; atopic dermatitis; cutaneous T-cell lymphoma; dupilumab; mycosis fungoides.
Conflict of interest statement
Conflicts of interest None disclosed.
Comment on
-
Diagnostic testing of eczematous dermatitis with incomplete response to dupilumab.J Am Acad Dermatol. 2022 Sep;87(3):692-695. doi: 10.1016/j.jaad.2022.03.047. Epub 2022 Mar 31. J Am Acad Dermatol. 2022. PMID: 35367296 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
